| Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation B Ensoli, L Buonaguro, G Barillari, V Fiorelli, R Gendelman, RA Morgan, ... Journal of virology 67 (1), 277-287, 1993 | 977 | 1993 |
| Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications L Buonaguro, ML Tornesello, FM Buonaguro Journal of virology 81 (19), 10209-10219, 2007 | 564 | 2007 |
| HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region HC Chang, F Samaniego, BC Nair, L Buonaguro, B Ensoli Aids 11 (12), 1421-1431, 1997 | 563 | 1997 |
| Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines L Buonaguro, G Barillari, HK Chang, CA Bohan, V Kao, R Morgan, ... Journal of virology 66 (12), 7159-7167, 1992 | 374 | 1992 |
| Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis J Hemelaar, R Elangovan, J Yun, L Dickson-Tetteh, I Fleminger, S Kirtley, ... The Lancet infectious diseases 19 (2), 143-155, 2019 | 333 | 2019 |
| Translating tumor antigens into cancer vaccines L Buonaguro, A Petrizzo, ML Tornesello, FM Buonaguro Clinical and Vaccine Immunology 18 (1), 23-34, 2011 | 305 | 2011 |
| Antimicrobial peptides as anticancer agents: functional properties and biological activities AL Tornesello, A Borrelli, L Buonaguro, FM Buonaguro, ML Tornesello Molecules 25 (12), 2850, 2020 | 261 | 2020 |
| Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis. G Barillari, L Buonaguro, V Fiorelli, J Hoffman, F Michaels, RC Gallo, ... Journal of immunology (Baltimore, Md.: 1950) 149 (11), 3727-3734, 1992 | 243 | 1992 |
| Update on head and neck cancer: current knowledge on epidemiology, risk factors, molecular features and novel therapies F Pezzuto, L Buonaguro, F Caponigro, F Ionna, N Starita, C Annunziata, ... Oncology 89 (3), 125-136, 2015 | 224 | 2015 |
| Antigen-specific vaccines for cancer treatment M Tagliamonte, A Petrizzo, ML Tornesello, FM Buonaguro, L Buonaguro Human vaccines & immunotherapeutics 10 (11), 3332-3346, 2014 | 187 | 2014 |
| Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections ML Tornesello, L Buonaguro, F Tatangelo, G Botti, F Izzo, FM Buonaguro Genomics 102 (2), 74-83, 2013 | 186 | 2013 |
| The role of microRNAs, long non-coding RNAs, and circular RNAs in cervical cancer ML Tornesello, R Faraonio, L Buonaguro, C Annunziata, N Starita, ... Frontiers in oncology 10, 150, 2020 | 178 | 2020 |
| Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer ML Tornesello, L Buonaguro, P Giorgi-Rossi, FM Buonaguro BioMed research international 2013, 2013 | 174 | 2013 |
| The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure L Buonaguro, FM Buonaguro, G Giraldo, B Ensoli Journal of virology 68 (4), 2677-2682, 1994 | 156 | 1994 |
| Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses L Buonaguro, ML Tornesello, M Tagliamonte, RC Gallo, LX Wang, ... Journal of virology 80 (18), 9134-9143, 2006 | 149 | 2006 |
| High-level expression of the HIV-1 Pr55gag polyprotein in transgenic tobacco chloroplasts N Scotti, F Alagna, E Ferraiolo, G Formisano, L Sannino, L Buonaguro, ... Planta 229, 1109-1122, 2009 | 135 | 2009 |
| Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro CA Bohan, F Kashanchi, B Ensoli, L Buonaguro, KA Boris-Lawrie, ... Gene expression 2 (4), 391, 1992 | 130 | 1992 |
| Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated endometrial cancers: new candidates for checkpoint blockade immunotherapy? P Gargiulo, C Della Pepa, S Berardi, D Califano, S Scala, L Buonaguro, ... Cancer treatment reviews 48, 61-68, 2016 | 128 | 2016 |
| Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix ML Tornesello, S Losito, G Benincasa, F Fulciniti, G Botti, S Greggi, ... Gynecologic oncology 121 (1), 32-42, 2011 | 118 | 2011 |
| Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma MW Löffler, C Mohr, L Bichmann, LK Freudenmann, M Walzer, ... Genome medicine 11, 1-16, 2019 | 112 | 2019 |
Franco M. BuonaguroDirector of Molecular Biology and Viral Oncology, Ist Naz Tumori - IRCCS "Fod Pascale" NapoliVahvistettu sähköpostiosoite verkkotunnuksessa istitutotumori.na.it
